Exploring RNA-based technology, its achievements, its future promises, and what it means for European healthcare: This was the aim of this year’s STOA Annual Lecture, the 20th edition of a yearly event organised by the European Parliament’s Panel for the Future of Science and Technology (STOA).
As its keynote lecturer, STOA welcomed Professor Özlem Türeci, co-founder and Chief Medical Officer of the German biotechnology company BioNTech. Together with Pfizer, BioNTech developed one of the most effective vaccines against Covid-19. But the possible applications of the RNA-based technology beyond vaccines are vast and its future is incredibly promising.
Watch our interview with Prof. Özlem Türeci.
Please accept YouTube cookies to play this video. By accepting you will be accessing content from YouTube, a service provided by an external third party.
If you accept this notice, your choice will be saved and the page will refresh.
Useful link:
• STOA annual lecture: the future of RNA-based technology
• STOA youtube channel
